ThisuniversalmousemonoclonalantibodywasgeneratedagainstplantactinACT1andrecognizesallplant(arABIdopsisACT1,2,3,4,7,8,11,12),animal(e.g.,humanmuscleandcytoplasmic),fungal,andprotistactins.
ActinexistsasaubiquitousproteininvolvedwithfilamentformationthatmakeuplargeportionsoftheCytoskeleton.Actinfilamentsinteractwithmyosintoassistinmusclecontractionaswellasaidingincellmotilityandcytokinesis.Invertebratestherearethreegroupsofactinisoforms:alpha,betaandgamma.Thealphaactinsarefoundinmuscletissuesandareamajorconstituentofthecontractileapparatus.Thebetaandgammaactinsco-existsinmostcelltypesascomponentsofthecytoskeletonandasmediatorsofinternalcellmotility.
FromthelaboratoryofRichardB.Meagher,PhD,UniversityofGeorgia.
PartofTheInvestigator"sAnnexeprogram.
ProductType: | Antibody |
AccessionID: | AEC09427 |
Antigen: | ArabidopsisActin(ACT1) |
MolecularWeight: | 45kDa |
Isotype: | IgG1 |
Clonality: | Monoclonal |
CloneName: | mAbGEa(5-16H1C8) |
Reactivity: | Human,Mouse,Rat,Bovine,Drosophila,Ovine,Plant,Xenopuslaevis,Yeast,Zebrafish |
Immunogen: | PurifiedArabidopsisactin(ACT1) |
SpeciesImmunized: | Mouse |
PurificationMethod: | ProteinGcolumn |
Buffer: | 0.1MSodiumPhosphate,pH7.4,0.15MNaCl,0.05%(w/v)SodiumAzide |
TestedApplications: | WB,IF,IHC,ELISA |
Storage: | -20C |
Shipped: | Coldpacks |
Antibody | Reactivity |
Actin[mAbGEa] | Universal |
Actin-1[mAb45a] | ACT1,3,4,12 |
Actin-11[mAb2345a] | ACT1,3,4,7,11,12 |
Actin-2[mAb13a] | ACT2,8,11 |
Actin-8[mAbGPa] | ACT1,2,3,4,7,8,11,12 |
WesternBlotAnalysis
TOP:ReactivitymAbGEawithhuman(HsBandHsA1,native;HsG1andHsA2,recombinant)andplant(At-ACT2,recombinant)actins.ThenumbersontheCoomassiebluestainedgelindicatetheamountofactinproteinloaded.BOTTOM:ReactivityofmAbGEawithC.intestinaliscytoplasmic-likeactinACTB1(CiB)anddiverseprotistactins.Ac,A.castellanii;Mb,
Adaptedfrom:Kandasamy,M.K.,etal.(2012)PlantCell24,2041-57.
Ifyoupublishresearchwiththisproduct,pleaseletusknowsowecanciteyourpaper.
Kerafast是位于波士顿的试剂公司,其主要任务是为全球科学界提供特有的实验室研究工具。其产品组合包括细胞系,抗体,小分子,染料等,其中许多在其他地方不可用。自2011年成立以来,全球超过160家机构的研究人员通过Kerafast在线平台提供了创新试剂,在这个平台上,材料可以快速访问,无需通过传统的材料转移协议流程。
在Kerafast,可通过MTA共享的材料,如抗体,细胞系,化合物,病毒载体,质粒等。随着文书工作,延误和成本不断上升,MTA交换过程正在成为学术实验室的沉重负担,因为Kerafast计划可以快速有效地进行补救。